Skip to content
Boca Raton City Online – Lifestyle
Author:
Daxor Corporation
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
March 9, 2026
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
March 9, 2026
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
March 7, 2026
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
March 5, 2026
←
Previous Page
1
2